Drug: Bicifadine: chronic pain clinical trials

Registry records that list "Drug: Bicifadine" as an intervention. Being studied does not mean an intervention works or is approved.

Trials with Canadian sites

Recruiting in Canada

Registry records in total

Trials in Canada

No trial with a Canadian site lists this intervention in this snapshot.

7 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Countries
A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy NCT00597649	Terminated	Phase 2	United States	XTL Biopharmaceuticals	2007-10
Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes NCT00553592	Unknown status	Phase 2	United States	XTL Biopharmaceuticals	2007-09
Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes NCT00553592	Unknown status	Phase 2	United States	XTL Biopharmaceuticals	2007-09
Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes NCT00553592	Unknown status	Phase 2	United States	XTL Biopharmaceuticals	2007-09
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain NCT00295724	Completed	Phase 3		DOV Pharmaceutical, Inc.	2005-10
Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain NCT00281645	Completed	Phase 3		DOV Pharmaceutical, Inc.	2004-12
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain NCT00295711	Completed	Phase 3		DOV Pharmaceutical, Inc.	2004-09

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.